| Klay Daniel Finley, MSOT OTR/L | |
|
3160 N Arizona Ave Ste 106, Chandler, AZ 85225-7122 | |
| (480) 699-4845 | |
| (480) 699-5085 |
| Full Name | Klay Daniel Finley |
|---|---|
| Gender | Male |
| Speciality | Occupational Therapy |
| Experience | 7 Years |
| Location | 3160 N Arizona Ave Ste 106, Chandler, Arizona |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1245730126 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 225X00000X | Occupational Therapist | (* (Not Available)) | Secondary |
| 225X00000X | Occupational Therapist | 7363 (Arizona) | Primary |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Advanced Neurologic Rehabilitation | 5395055859 | 19 |
News Archive
State policymakers are growing increasingly anxious in the face of administration signals that key guidance on federal exchanges may not be coming until late 2011 or early 2012 — if they're coming at all. The administration appears to have decided that it does not need to issue a rule outlining the operation of a federal fallback exchange, according to sources familiar with the administration's thinking.
A robotic arm device developed to assist orthopedic surgeons with performing partial knee replacement surgery for early to mid-stage osteoarthritis is now available at NewYork-Presbyterian Hospital/Columbia University Medical Center. The technology was approved by the FDA in 2005, and to date nearly 5,000 cases have been performed in the U.S.
Legislation that criminalizes homosexual acts in Uganda did not, as expected, make it to the floor of the country's Parliament on Friday, meaning "the bill is essentially dead, for the moment," PRI's "The World" reports.
Washington Examiner: "Lawmakers in Virginia and Maryland are bracing for a congressional impasse over millions of dollars in health care funding that threatens to thrust both states into the red. The Medicaid funding is set to expire in January, and a measure to extend it is stalled in the Senate over concerns about the ballooning federal deficit.
Semafore Pharmaceuticals announced today that the U.S. Food and Drug Administration (FDA) has granted orphan drug designation to the Company's SF1126 product candidate for the treatment of B-cell chronic lymphocytic leukemia (CLL). In April 2010, the Company initiated an expansion of its ongoing Phase I clinical study into this disease setting. SF1126 is a novel peptidic prodrug that converts to LY294002, one of the most widely studied small molecule inhibitors of both phosphatidylinositol 3-kinase (PI3K) and mammalian target of rapamycin (mTOR).
› Verified 9 days ago
| Provider Name | Spooner Physical Therapy & Hand Rehab, Pc |
|---|---|
| Provider Type | Part B Supplier - Clinic/group Practice |
| Provider Identifiers | NPI Number: 1184730095 PECOS PAC ID: 3476440447 Enrollment ID: O20040303000811 |
News Archive
State policymakers are growing increasingly anxious in the face of administration signals that key guidance on federal exchanges may not be coming until late 2011 or early 2012 — if they're coming at all. The administration appears to have decided that it does not need to issue a rule outlining the operation of a federal fallback exchange, according to sources familiar with the administration's thinking.
A robotic arm device developed to assist orthopedic surgeons with performing partial knee replacement surgery for early to mid-stage osteoarthritis is now available at NewYork-Presbyterian Hospital/Columbia University Medical Center. The technology was approved by the FDA in 2005, and to date nearly 5,000 cases have been performed in the U.S.
Legislation that criminalizes homosexual acts in Uganda did not, as expected, make it to the floor of the country's Parliament on Friday, meaning "the bill is essentially dead, for the moment," PRI's "The World" reports.
Washington Examiner: "Lawmakers in Virginia and Maryland are bracing for a congressional impasse over millions of dollars in health care funding that threatens to thrust both states into the red. The Medicaid funding is set to expire in January, and a measure to extend it is stalled in the Senate over concerns about the ballooning federal deficit.
Semafore Pharmaceuticals announced today that the U.S. Food and Drug Administration (FDA) has granted orphan drug designation to the Company's SF1126 product candidate for the treatment of B-cell chronic lymphocytic leukemia (CLL). In April 2010, the Company initiated an expansion of its ongoing Phase I clinical study into this disease setting. SF1126 is a novel peptidic prodrug that converts to LY294002, one of the most widely studied small molecule inhibitors of both phosphatidylinositol 3-kinase (PI3K) and mammalian target of rapamycin (mTOR).
› Verified 9 days ago
| Provider Name | Advanced Neurologic Rehabilitation |
|---|---|
| Provider Type | Part B Supplier - Clinic/group Practice |
| Provider Identifiers | NPI Number: 1922482017 PECOS PAC ID: 5395055859 Enrollment ID: O20151112001859 |
News Archive
State policymakers are growing increasingly anxious in the face of administration signals that key guidance on federal exchanges may not be coming until late 2011 or early 2012 — if they're coming at all. The administration appears to have decided that it does not need to issue a rule outlining the operation of a federal fallback exchange, according to sources familiar with the administration's thinking.
A robotic arm device developed to assist orthopedic surgeons with performing partial knee replacement surgery for early to mid-stage osteoarthritis is now available at NewYork-Presbyterian Hospital/Columbia University Medical Center. The technology was approved by the FDA in 2005, and to date nearly 5,000 cases have been performed in the U.S.
Legislation that criminalizes homosexual acts in Uganda did not, as expected, make it to the floor of the country's Parliament on Friday, meaning "the bill is essentially dead, for the moment," PRI's "The World" reports.
Washington Examiner: "Lawmakers in Virginia and Maryland are bracing for a congressional impasse over millions of dollars in health care funding that threatens to thrust both states into the red. The Medicaid funding is set to expire in January, and a measure to extend it is stalled in the Senate over concerns about the ballooning federal deficit.
Semafore Pharmaceuticals announced today that the U.S. Food and Drug Administration (FDA) has granted orphan drug designation to the Company's SF1126 product candidate for the treatment of B-cell chronic lymphocytic leukemia (CLL). In April 2010, the Company initiated an expansion of its ongoing Phase I clinical study into this disease setting. SF1126 is a novel peptidic prodrug that converts to LY294002, one of the most widely studied small molecule inhibitors of both phosphatidylinositol 3-kinase (PI3K) and mammalian target of rapamycin (mTOR).
› Verified 9 days ago
| Provider Name | Theraplay4kidz, Llc |
|---|---|
| Provider Type | Part B Supplier - Clinic/group Practice |
| Provider Identifiers | NPI Number: 1750727798 PECOS PAC ID: 3476823972 Enrollment ID: O20190321000727 |
News Archive
State policymakers are growing increasingly anxious in the face of administration signals that key guidance on federal exchanges may not be coming until late 2011 or early 2012 — if they're coming at all. The administration appears to have decided that it does not need to issue a rule outlining the operation of a federal fallback exchange, according to sources familiar with the administration's thinking.
A robotic arm device developed to assist orthopedic surgeons with performing partial knee replacement surgery for early to mid-stage osteoarthritis is now available at NewYork-Presbyterian Hospital/Columbia University Medical Center. The technology was approved by the FDA in 2005, and to date nearly 5,000 cases have been performed in the U.S.
Legislation that criminalizes homosexual acts in Uganda did not, as expected, make it to the floor of the country's Parliament on Friday, meaning "the bill is essentially dead, for the moment," PRI's "The World" reports.
Washington Examiner: "Lawmakers in Virginia and Maryland are bracing for a congressional impasse over millions of dollars in health care funding that threatens to thrust both states into the red. The Medicaid funding is set to expire in January, and a measure to extend it is stalled in the Senate over concerns about the ballooning federal deficit.
Semafore Pharmaceuticals announced today that the U.S. Food and Drug Administration (FDA) has granted orphan drug designation to the Company's SF1126 product candidate for the treatment of B-cell chronic lymphocytic leukemia (CLL). In April 2010, the Company initiated an expansion of its ongoing Phase I clinical study into this disease setting. SF1126 is a novel peptidic prodrug that converts to LY294002, one of the most widely studied small molecule inhibitors of both phosphatidylinositol 3-kinase (PI3K) and mammalian target of rapamycin (mTOR).
› Verified 9 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Klay Daniel Finley, MSOT OTR/L 3160 N Arizona Ave Ste 106, Chandler, AZ 85225-7122 Ph: (480) 699-4845 | Klay Daniel Finley, MSOT OTR/L 3160 N Arizona Ave Ste 106, Chandler, AZ 85225-7122 Ph: (480) 699-4845 |
News Archive
State policymakers are growing increasingly anxious in the face of administration signals that key guidance on federal exchanges may not be coming until late 2011 or early 2012 — if they're coming at all. The administration appears to have decided that it does not need to issue a rule outlining the operation of a federal fallback exchange, according to sources familiar with the administration's thinking.
A robotic arm device developed to assist orthopedic surgeons with performing partial knee replacement surgery for early to mid-stage osteoarthritis is now available at NewYork-Presbyterian Hospital/Columbia University Medical Center. The technology was approved by the FDA in 2005, and to date nearly 5,000 cases have been performed in the U.S.
Legislation that criminalizes homosexual acts in Uganda did not, as expected, make it to the floor of the country's Parliament on Friday, meaning "the bill is essentially dead, for the moment," PRI's "The World" reports.
Washington Examiner: "Lawmakers in Virginia and Maryland are bracing for a congressional impasse over millions of dollars in health care funding that threatens to thrust both states into the red. The Medicaid funding is set to expire in January, and a measure to extend it is stalled in the Senate over concerns about the ballooning federal deficit.
Semafore Pharmaceuticals announced today that the U.S. Food and Drug Administration (FDA) has granted orphan drug designation to the Company's SF1126 product candidate for the treatment of B-cell chronic lymphocytic leukemia (CLL). In April 2010, the Company initiated an expansion of its ongoing Phase I clinical study into this disease setting. SF1126 is a novel peptidic prodrug that converts to LY294002, one of the most widely studied small molecule inhibitors of both phosphatidylinositol 3-kinase (PI3K) and mammalian target of rapamycin (mTOR).
› Verified 9 days ago
Sarah J. Whitney, MSOTR/L Occupational Therapist Medicare: Not Enrolled in Medicare Practice Location: 575 W Pecos Rd Apt 1127, Chandler, AZ 85225 Phone: 602-793-1492 | |
Taylor Knoll, OTR/L Occupational Therapist Medicare: Not Enrolled in Medicare Practice Location: 3160 N Arizona Ave Ste 105, Chandler, AZ 85225 Phone: 480-365-9981 | |
Kendra Alaine Bauman, O.T. Occupational Therapist Medicare: Not Enrolled in Medicare Practice Location: 1525 W Frye Rd, Chandler, AZ 85224 Phone: 480-812-7000 | |
Mrs. Carole Beth Gates, Occupational Therapist Medicare: Not Enrolled in Medicare Practice Location: 6283 W Megan St, Chandler, AZ 85226 Phone: 480-634-4993 | |
Kylie Metherd, Occupational Therapist Medicare: Not Enrolled in Medicare Practice Location: 2715 S Alma School Rd Ste 3, Chandler, AZ 85286 Phone: 480-508-5252 | |
Christine Rose Prigge, OT Occupational Therapist Medicare: Not Enrolled in Medicare Practice Location: 621 N Tercera Ave, Chandler, AZ 85226 Phone: 480-239-1595 Fax: 480-855-3507 | |
Amy Carr, OTR/L Occupational Therapist Medicare: Not Enrolled in Medicare Practice Location: 2175 N Alma School Rd Ste A106, Chandler, AZ 85224 Phone: 480-855-0474 |